These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1909828)

  • 1. Complement activation pathways associated with islet cell surface antibody (ICSA) derived from child patients with insulin-dependent diabetes mellitus (IDDM).
    Okada S; Ichiki K; Sato K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    Acta Med Okayama; 1991 Jun; 45(3):185-6. PubMed ID: 1909828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?
    Okada S; Sato K; Ichiki K; Tanokuchi S; Ishii K; Ota Z; Takeda A
    J Int Med Res; 1991; 19(3):234-6. PubMed ID: 1936512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclasses of islet cell surface antibodies and their cytotoxic activity against pancreatic islet cells.
    Suzuki M; Kawazu S; Negishi K; Watanabe T; Hokama A; Fujiki Y; Takahashi Y; Ishii J
    Diabetes Res Clin Pract; 1987; 3(4):215-20. PubMed ID: 3304909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release.
    Sadovnikova NV; Pankov YA; Fedotov VP; Czernushkina AV; Zhukovsky MA; Shcherbacheva LN
    Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.
    Dobersen MJ; Scharff JE; Ginsberg-Fellner F; Notkins AL
    N Engl J Med; 1980 Dec; 303(26):1493-8. PubMed ID: 7001237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
    Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
    Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of islet cell surface antigen reactions with islet cell surface antibodies (ICSA)].
    Hakamata M; Itoh M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jul; 66(7):700-14. PubMed ID: 2204556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for enhanced rates of complement activation in serum from patients with newly diagnosed insulin-dependent diabetes mellitus exposed to rat islet cells and complement-dependent induction of islet cell apoptosis.
    Caraher EM; Conroy SJ; Newsholme P
    J Endocrinol; 1999 Jul; 162(1):143-53. PubMed ID: 10396031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors.
    Hehmke B; Schröder D; Klöting I; Kohnert KD
    J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel microwell indirect immunofluorescence assay to detect antibodies against islet cell surface antigens in insulin-dependent diabetes mellitus.
    Matsuba I; Lernmark A
    Reg Immunol; 1990; 3(1):23-8. PubMed ID: 2223554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.
    Okada S; Sato K; Miyai Y; Masaki Y; Higuchi T; Ogino Y; Ota Z
    Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic.
    Radillo O; Nocera A; Leprini A; Barocci S; Mollnes TE; Pocecco M; Pausa M; Valente U; Betterle C; Tedesco F
    Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of specificity of islet cell surface antibodies (ICSA) in IDDM.
    Peterson C; Campbell IL; Harrison LC
    Diabetes Res Clin Pract; 1992 Jul; 17(1):33-42. PubMed ID: 1511659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological events in new onset diabetes.
    Charles M; Suzuki M; Sundsmo J; Waldeck N; Negishi K; Slater L; Ong K; Buckingham B; Kershnar A
    Biomed Biochim Acta; 1984; 43(5):615-9. PubMed ID: 6383365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro.
    Sai P; Boitard C; Debray-Sachs M; Pouplard A; Assan R; Hamburger J
    Diabetes; 1981 Dec; 30(12):1051-7. PubMed ID: 7030831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
    Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
    Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms.
    Schaapherder AF; Wolvekamp MC; te Bulte MT; Bouwman E; Gooszen HG; Daha MR
    Transplantation; 1996 Jul; 62(1):29-33. PubMed ID: 8693539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.